New York, March 07, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Cannabidiol Industry” – https://www.reportlinker.com/p06031037/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Cannabidiol Market to Reach $21.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Cannabidiol estimated at US$8.2 Billion in the year 2022, is projected to reach a revised size of US$21.2 Billion by 2030, growing at aCAGR of 12.6% over the period 2022-2030. Hemp, one of the segments analyzed in the report, is projected to record 14.3% CAGR and reach US$14.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Marijuana segment is readjusted to a revised 9.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 18.6% CAGR
The Cannabidiol market in the U.S. is estimated at US$2.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 18.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.6% and 10.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.
Select Competitors (Total 47 Featured)
– ABcann Medicinals, Inc.
– Aphria, Inc
– Aurora Cannabis
– Canopy Growth Corporation
– CBD LION
– CBDfxBota
– CBDistillery
– cbdMD
– GW Pharmaceuticals, plc
– Kazmira
– Maricann, Inc. (Wayland Group Corporation)
– Medixcbd
– Medterra
– NuLeaf Naturals
– Organigram Holding, Inc.
– The CBD Company
– The Cronos Group
– Tikun Olam
– Tilray
Read the full report: https://www.reportlinker.com/p06031037/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Cannabidiol – Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for B2C
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 2: World Historic Review for B2C by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for B2C by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for B2B
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 5: World Historic Review for B2B by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for B2B by Geographic Region –
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Medical by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Medical by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Medical by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Personal Use by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Personal Use by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 12: World 16-Year Perspective for Personal Use by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Pharmaceuticals by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Pharmaceuticals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Pharmaceuticals by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Wellness by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Wellness by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 18: World 16-Year Perspective for Wellness by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 19: World Cannabidiol Market Analysis of Annual Sales in
US$ Million for Years 2014 through 2030
Table 20: World Recent Past, Current & Future Analysis for
Cannabidiol by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Cannabidiol by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 22: World 16-Year Perspective for Cannabidiol by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for Hemp
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 24: World Historic Review for Hemp by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Hemp by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Marijuana by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Marijuana by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 28: World 16-Year Perspective for Marijuana by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in the United States for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 30: USA Historic Review for Cannabidiol by Distribution
Channel – B2B and B2C Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 34: USA 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal Use,
Pharmaceuticals and Wellness for the Years 2014, 2023 & 2030
Table 35: USA Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 36: USA Historic Review for Cannabidiol by Source – Hemp
and Marijuana Markets – Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 37: USA 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana for
the Years 2014, 2023 & 2030
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 39: Canada Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 40: Canada 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 41: Canada Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 42: Canada Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 43: Canada 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 44: Canada Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 45: Canada Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 46: Canada 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
JAPAN
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 48: Japan Historic Review for Cannabidiol by Distribution
Channel – B2B and B2C Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 49: Japan 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 50: Japan Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 51: Japan Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 52: Japan 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 53: Japan Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 54: Japan Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 55: Japan 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana for
the Years 2014, 2023 & 2030
CHINA
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 57: China Historic Review for Cannabidiol by Distribution
Channel – B2B and B2C Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 58: China 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 59: China Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 60: China Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 61: China 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 62: China Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 63: China Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 64: China 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana for
the Years 2014, 2023 & 2030
EUROPE
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 66: Europe Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 67: Europe 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 68: Europe Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 69: Europe Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 70: Europe 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 71: Europe Recent Past, Current & Future Analysis for
Cannabidiol by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR
Table 72: Europe Historic Review for Cannabidiol by Geographic
Region – France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets – Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 73: Europe 16-Year Perspective for Cannabidiol by
Geographic Region – Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030
Table 74: Europe Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 75: Europe Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 76: Europe 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
FRANCE
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 78: France Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 79: France 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 80: France Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 81: France Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 82: France 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 83: France Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 84: France Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 85: France 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
GERMANY
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 87: Germany Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 88: Germany 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 89: Germany Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 90: Germany Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 91: Germany 16-Year Perspective for Cannabidiol by
End-Use – Percentage Breakdown of Value Sales for Medical,
Personal Use, Pharmaceuticals and Wellness for the Years 2014,
2023 & 2030
Table 92: Germany Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 93: Germany Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 94: Germany 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 96: Italy Historic Review for Cannabidiol by Distribution
Channel – B2B and B2C Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 97: Italy 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 98: Italy Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 99: Italy Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 100: Italy 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 101: Italy Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 102: Italy Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 103: Italy 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
UNITED KINGDOM
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in the United Kingdom for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 105: UK Historic Review for Cannabidiol by Distribution
Channel – B2B and B2C Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 106: UK 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 107: UK Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 108: UK Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 109: UK 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal Use,
Pharmaceuticals and Wellness for the Years 2014, 2023 & 2030
Table 110: UK Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 111: UK Historic Review for Cannabidiol by Source – Hemp
and Marijuana Markets – Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 112: UK 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana for
the Years 2014, 2023 & 2030
SPAIN
Table 113: Spain Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 114: Spain Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 115: Spain 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 116: Spain Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 117: Spain Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 118: Spain 16-Year Perspective for Cannabidiol by End-Use –
Percentage Breakdown of Value Sales for Medical, Personal
Use, Pharmaceuticals and Wellness for the Years 2014, 2023 &
2030
Table 119: Spain Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 120: Spain Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 121: Spain 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
RUSSIA
Table 122: Russia Recent Past, Current & Future Analysis for
Cannabidiol by Distribution Channel – B2B and B2C – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 123: Russia Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 124: Russia 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 125: Russia Recent Past, Current & Future Analysis for
Cannabidiol by End-Use – Medical, Personal Use, Pharmaceuticals
and Wellness – Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 126: Russia Historic Review for Cannabidiol by End-Use –
Medical, Personal Use, Pharmaceuticals and Wellness Markets –
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 127: Russia 16-Year Perspective for Cannabidiol by
End-Use – Percentage Breakdown of Value Sales for Medical,
Personal Use, Pharmaceuticals and Wellness for the Years 2014,
2023 & 2030
Table 128: Russia Recent Past, Current & Future Analysis for
Cannabidiol by Source – Hemp and Marijuana – Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 129: Russia Historic Review for Cannabidiol by Source –
Hemp and Marijuana Markets – Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 130: Russia 16-Year Perspective for Cannabidiol by Source –
Percentage Breakdown of Value Sales for Hemp and Marijuana
for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 131: Rest of Europe Recent Past, Current & Future
Analysis for Cannabidiol by Distribution Channel – B2B and B2C –
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 132: Rest of Europe Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 133: Rest of Europe 16-Year Perspective for Cannabidiol
by Distribution Channel – Percentage Breakdown of Value Sales
for B2B and B2C for the Years 2014, 2023 & 2030
Table 134: Rest of Europe Recent Past, Current & Future
Analysis for Cannabidiol by End-Use – Medical, Personal Use,
Pharmaceuticals and Wellness – Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 135: Rest of Europe Historic Review for Cannabidiol by
End-Use – Medical, Personal Use, Pharmaceuticals and Wellness
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 136: Rest of Europe 16-Year Perspective for Cannabidiol
by End-Use – Percentage Breakdown of Value Sales for Medical,
Personal Use, Pharmaceuticals and Wellness for the Years 2014,
2023 & 2030
Table 137: Rest of Europe Recent Past, Current & Future
Analysis for Cannabidiol by Source – Hemp and Marijuana –
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 138: Rest of Europe Historic Review for Cannabidiol by
Source – Hemp and Marijuana Markets – Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 139: Rest of Europe 16-Year Perspective for Cannabidiol
by Source – Percentage Breakdown of Value Sales for Hemp and
Marijuana for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Cannabidiol Market Presence – Strong/Active/Niche/Trivial – Key
Competitors in Asia-Pacific for 2023 (E)
Table 140: Asia-Pacific Recent Past, Current & Future Analysis
for Cannabidiol by Distribution Channel – B2B and B2C –
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 141: Asia-Pacific Historic Review for Cannabidiol by
Distribution Channel – B2B and B2C Markets – Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 142: Asia-Pacific 16-Year Perspective for Cannabidiol by
Distribution Channel – Percentage Breakdown of Value Sales for
B2B and B2C for the Years 2014, 2023 & 2030
Table 143: Asia-Pacific Recent Past, Current & Future Analysis
for Cannabidiol by End-Use – Medical, Personal Use,
Pharmaceuticals and Wellness – Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 144: Asia-Pacific Historic Review for Cannabidiol by
End-Use – Medical, Personal Use, Pharmaceuticals and Wellness
Markets – Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 145: Asia-Pacific 16-Year Perspective for Cannabidiol by
End-Use – Percentage Breakdown of Value Sales for Medical,
Personal Use, Pharmaceuticals and Wellness for the Years 2014,
2023 & 2030
Table 146: Asia-Pacific Recent Past, Current & Future Analysis
for Cannabidiol by Geographic Region – Australia, India, South
Korea and Rest of Asia-Pacific Markets – Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06031037/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Source: Globenewswire